Postpartum Depression

• FDA approval · 2026-04-20
  FDA Approved: ZURZUVAE — Supplemental Application (Biogen MA Inc.)

  The FDA approved a supplemental application for Zurzuvae (zuranolone) from Biogen MA Inc., resulting in an updated label under the supplemen…

• EMA approval · 2025-10-31
  EMA Authorised: Zurzuvae (zuranolone) — Biogen Netherlands B.V.

  The EMA authorised Zurzuvae (zuranolone) by Biogen Netherlands B.V. for depression and postpartum depression.

• CLINICAL_TRIALS approval · 2025-09-15
  Clinical Trial Update: Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression

  Expanded Access Protocol update for Zulresso (brexanolone) injection to treat postpartum depression in adults; the drug is listed as approve…